Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge
Open Access
- 1 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 78 (3)
- https://doi.org/10.1093/femspd/ftaa025
Abstract
Effective herd immunity against SARS-CoV-2 will be determined on many factors: the percentage of the immune population, the length and effectiveness of the immune response and the stability of the viral epitopes. The required percentage of immune individuals has been estimated to be 50-66% of the population which, given the current infection rates, will take long to be achieved. Furthermore, data from SARS-CoV suggest that the duration of immunity may not be sufficiently significant, while the immunity response against SARS-CoV-2 may not be efficiently effective in all patients, as relapses have already been reported. In addition, the development of mutant strains, which has already been documented, can cause the reemergence of the epidemic. In conclusion, the development of an effective vaccine is an urgent necessity, as long-term natural immunity to SARS-CoV-2 may not be sufficient for the control of the current and future outbreaks.Keywords
This publication has 17 references indexed in Scilit:
- Positive RT-PCR Test Results in Patients Recovered From COVID-19Jama-Journal Of The American Medical Association, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Paleobiogeographic distribution of the Early Cretaceous radiolarian Turbocapsula costata and its correlation potentialPaleontological Research, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countriesJournal of Infection, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Meat Quality AnalysisPublished by Elsevier BV ,2020
- Vaccination-induced herd immunity: Successes and challengesJournal of Allergy and Clinical Immunology, 2018
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up StudyThe Journal of Immunology, 2011
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006